Donna Wright

9.5k total citations · 2 hit papers
9 papers, 7.9k citations indexed

About

Donna Wright is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology and Clinical Psychology. According to data from OpenAlex, Donna Wright has authored 9 papers receiving a total of 7.9k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Endocrinology, Diabetes and Metabolism, 2 papers in Pharmacology and 2 papers in Clinical Psychology. Recurrent topics in Donna Wright's work include Diabetes Treatment and Management (6 papers), Diabetes Management and Research (6 papers) and Pharmacology and Obesity Treatment (2 papers). Donna Wright is often cited by papers focused on Diabetes Treatment and Management (6 papers), Diabetes Management and Research (6 papers) and Pharmacology and Obesity Treatment (2 papers). Donna Wright collaborates with scholars based in United Kingdom and Canada. Donna Wright's co-authors include Matthews, Eugene Manley, R. C. Turner, C A Cull, Honora H. McElroy, Irene Stratton, Michael Gnant, Charles Fox, David R. Hadden and R R Holman and has published in prestigious journals such as The Lancet, Journal of Advanced Nursing and Psychiatric Services.

In The Last Decade

Donna Wright

8 papers receiving 7.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

1998 7.2k citations R. C. Turner, Charles Fox et al. The Lancet profile →
Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs

2012 610 citations Nick Hex, Chris Bartlett et al. Diabetic Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Donna Wright United Kingdom	6	5.8k	1.4k	1.4k	990	860	9	7.9k
R R Holman United Kingdom	10	5.5k 0.9×	1.4k 1.0×	1.4k 1.0×	998 1.0×	751 0.9×	48	7.6k
C A Cull United Kingdom	6	5.8k 1.0×	1.6k 1.1×	1.4k 1.1×	988 1.0×	748 0.9×	6	7.9k
Matthews United States	7	5.4k 0.9×	1.4k 1.0×	1.3k 0.9×	1.0k 1.1×	759 0.9×	27	7.5k
Eugene Manley United States	6	5.3k 0.9×	1.4k 1.0×	1.3k 0.9×	959 1.0×	721 0.8×	13	7.2k
Honora H. McElroy United States	6	5.3k 0.9×	1.4k 1.0×	1.3k 0.9×	994 1.0×	729 0.8×	6	7.3k
Nicholas Emanuele United States	35	5.4k 0.9×	1.6k 1.1×	1.1k 0.8×	1.6k 1.6×	605 0.7×	138	8.3k
M. Angelyn Bethel United States	18	5.4k 0.9×	1.8k 1.3×	1.3k 0.9×	1.0k 1.1×	719 0.8×	46	7.1k
Jorge Luiz Gross Brazil	51	5.8k 1.0×	2.3k 1.6×	2.3k 1.7×	1.4k 1.4×	1.0k 1.2×	234	10.5k
Linong Ji China	36	4.5k 0.8×	1.7k 1.2×	1.5k 1.1×	758 0.8×	1.1k 1.2×	251	7.3k
Enrico Cagliero United States	41	3.1k 0.5×	869 0.6×	818 0.6×	689 0.7×	1.1k 1.3×	82	6.2k

Countries citing papers authored by Donna Wright

Since Specialization

Citations

This map shows the geographic impact of Donna Wright's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donna Wright with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donna Wright more than expected).

Fields of papers citing papers by Donna Wright

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donna Wright. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donna Wright. The network helps show where Donna Wright may publish in the future.

Co-authorship network of co-authors of Donna Wright

This figure shows the co-authorship network connecting the top 25 collaborators of Donna Wright. A scholar is included among the top collaborators of Donna Wright based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donna Wright. Donna Wright is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Basson, Mickaël, et al.. (2017). The Cost-effectiveness of Dulaglutide 1.5mg versus Exenatide QW for the Treatment of Patients with Type 2 Diabetes Mellitus in France. Diabetes Therapy. 9(1). 13–25. 12 indexed citations

2.

Hex, Nick, Chris Bartlett, Donna Wright, Matthew Taylor, & Danielle Varley. (2012). Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabetic Medicine. 29(7). 855–862. 610 indexed citations breakdown →

3.

Hex, Nick, Chris Bartlett, Donna Wright, Matthew Taylor, & Danielle Varley. (2012). Article: Health Economics Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs.

4.

Samyshkin, Yevgeniy, et al.. (2011). Modeling the lifetime costs of insulin glargine and insulin detemir in type 1 and type 2 diabetes patients in Canada: a meta-analysis and a cost-minimization analysis. Journal of Medical Economics. 14(2). 207–216. 11 indexed citations

5.

Fakhoury, Walid, C LeReun, & Donna Wright. (2010). A Meta-Analysis of Placebo-Controlled Clinical Trials Assessing the Efficacy and Safety of Incretin-Based Medications in Patients with Type 2 Diabetes. Pharmacology. 86(1). 44–57. 96 indexed citations

6.

Fakhoury, Walid & Donna Wright. (2001). Training, Communication, and Information Needs of Mental Health Counselors in the United Kingdom. Psychiatric Services. 52(9). 1237–1241. 3 indexed citations

7.

Fakhoury, Walid & Donna Wright. (2000). Communication and information needs of a random sample of community psychiatric nurses in the United Kingdom. Journal of Advanced Nursing. 32(4). 871–880. 15 indexed citations

8.

Turner, R. C., Charles Fox, Matthews, et al.. (1998). Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.. The Lancet. 7180 indexed citations breakdown →

9.

Wright, Donna, Harold Carlson, Jerome M. Hershman, & Evan Adelstein. (1987). Lack of Effect of Warfarin on L-Thyroxine Metabolism. Hormone and Metabolic Research. 19(7). 323–324. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact